Close
Written By: Jeffrey Atlas, PA-C, Health Content Writer
Medically Reviewed By: Dr. Gopal Grandhige, MD, FACS, Board-Certified Surgeon
Last Reviewed: November 3, 2026
DSIP and sleep research covers less ground than the peptide’s name promises. Six human insomnia studies, run between 1981 and 1992. Each one enrolled between six and eighteen patients. Every controlled trial delivered the peptide through an IV line in a sleep lab. In July 2026, an FDA advisory panel read that record and voted against letting pharmacies compound it. That was the only rejection out of seven peptides reviewed that week.
Formation doesn’t offer DSIP. Patients ask anyway, which is why we’ve already covered how DSIP gets used.
DSIP, or delta sleep-inducing peptide, is a nine-amino-acid molecule. Swiss researchers pulled it from rabbit blood in 1977 after electrically stimulating the thalamus. DSIP and sleep research refers to that small set of human trials from the 1980s and early 1990s. All of them used intravenous dosing. The results split sharply depending on which group ran the study.
A handful of small trials in chronic insomnia, plus a much more consistent animal literature. The gap between the animal and the human data is the whole story.
In rabbits, cats and rats, the peptide raised delta wave power on EEG. That held across species and across routes. Delta waves mark the deepest stage of non-REM sleep, and that finding is where the name came from.
Sleep wasn’t the only target either, since the conditions DSIP was studied for also included narcolepsy and opioid withdrawal.
The human side never caught up on any of them. Part of the problem is speed. The peptide clears fast, with a measured half-life of three to six minutes in dogs and roughly two to three minutes in rats. In human serum tested outside the body, it broke down inside ten minutes.
The most quotable human claim comes from a 1984 open study of seven patients with severe insomnia. After ten injections, sleep was reported as normalized for three to seven months in all but one case. That’s the source of the idea that a short course resets sleep for months. It was an open study with no control group and seven people in it.
Because the strong positive results cluster inside a single research network, and the independent replications came back weak.
The most cited positive trial ran in 14 middle-aged patients in 1987. Average sleep onset latency fell from 58.4 minutes at baseline to 27.6 minutes after the last of seven injections. The paper called itself placebo-controlled. It had no placebo arm. Patients were compared against a separate matched group of healthy sleepers.
Then the outside labs tried.
A 1992 double-blind study put 16 chronic insomniacs through five nights in a sleep laboratory. Half got 25 nmol/kg intravenously in the early evening before each of three treatment nights, half got glucose. Sleep latency came out shorter on the peptide. Nothing else moved. Subjective sleep quality didn’t change at all. The authors flagged a catch. The placebo group’s latency on one night ran unusually high, so even that single difference deserves caution. They concluded short-term treatment isn’t likely to be of major therapeutic benefit.
A 1987 crossover study in six patients found no significant difference against baseline or placebo either.
So the record isn’t empty. It’s split, and the split runs along the line between the group that discovered the molecule and everyone else.
This is the detail that should stop most people, and almost nobody mentions it.
Every piece of controlled human sleep data on this peptide comes from intravenous dosing in a laboratory. The product sold online and discussed in wellness circles is a subcutaneous injection. The FDA briefing document prepared for the 2026 review states plainly that no study tested the proposed subcutaneous route at all. Not for insomnia, not for narcolepsy, not for opioid withdrawal.
Different route, different absorption, different peak, different everything. A four-minute IV infusion of a peptide with a several-minute half-life is not the same event as a shot in the abdomen.
The same document lists what else is missing. No United States Pharmacopeia monograph. No repeat-dose toxicity studies. No reproductive or developmental studies. Certificates of analysis submitted by the nominating pharmacies carried no impurity limits, no aggregate testing and no endotoxin testing. For an injected peptide, aggregates are what drive immune reactions.
One more detail. The free base form dissolves in water at about 0.5 mg per mL, and the nominated product was a 1 mg per mL injection. The agency couldn’t work out how that formulation would hold together.
On July 24, 2026, the Pharmacy Compounding Advisory Committee voted against adding emideltide, the compounding name for DSIP, to the 503A bulk substances list.
The context makes the vote louder. The committee met over two days to review seven peptides. FDA staff had recommended against all seven. The committee overruled its own agency six times. It still said no to this one.
Votes like that are advisory. Nothing changed in federal law that day, and formal rulemaking takes far longer than a news cycle. But the panel that was willing to disagree with its own scientists six times in two days would not do it for this molecule.
Formation works only with human-grade compounds from licensed pharmacies. Research-grade material is a different category, and administering, prescribing, purchasing or dispensing it isn’t legal.
That line matters more here than almost anywhere else, because there’s currently no legal compounding route for this peptide at all. Anything sold as DSIP right now is research-grade by definition. We’ve written separately about what FDA scientists flagged in the run-up to that vote.
Two clearly, and the peptide’s claim on either one is unproven.
Hallmarks addressed by sleep itself: altered intercellular communication and chronic inflammation. Deep sleep is when cortisol bottoms out, growth hormone pulses, and the brain runs its overnight clearance. Lose it and the signaling between your cells drifts while background inflammation climbs.
DSIP was proposed to reach the first one through cortisol and ACTH. The animal work suggests it acts partly by nudging enkephalin release rather than by flipping a sleep switch directly. The FDA reviewers noted the flip side of that mechanism. Compounds that push endorphin release in reward circuits can carry reinforcing properties, and no abuse-potential study was ever submitted.
That’s a proposed mechanism with an unmeasured risk attached. It isn’t a hallmarks story yet. Reinforcement potential is one reason who shouldn’t take peptides stays a screening question here rather than a disclaimer at the bottom of a page.
Health isn’t a straight line up. It’s an oscillation between building and renewal, and sleep is the anchor of the renewal side.
The building side is protein, resistance training, growth hormone, repair. The renewal side is fasting windows, autophagy, cellular cleanup, and sleep. Most people wreck themselves by living permanently on one side. Always training, never recovering. Always eating, never fasting.
Trying to buy the renewal side with an injection is the same mistake in a new package.
There’s also a compensation problem. Push one sleep pathway hard and the body answers through another. Circadian timing, adenosine pressure, cortisol rhythm and core temperature all have a vote. Lean on a single lever and the system routes around you, which is why we chase goals through several pathways at once.
The habits that fit this pathway are dull and they work. Same wake time every day, weekends included. Morning light within an hour of getting up. A cold, dark room. Alcohol off the table, since it flattens slow-wave sleep even when it knocks you out. Caffeine cut by early afternoon. Hard training earlier in the day. Enough protein to support overnight repair. Peptides like Epitalon for sleep sharpen work you’re already doing. They don’t do the work.
We screen first and we’re willing to say no. Saying no to a peptide someone came in asking for is part of the job.
Formation is a regenerative medicine clinic in Tampa. We hold SSRP and ISSCA certifications, the bodies that certify peptide, exosome and stem cell practice. Jeff Atlas, PA-C performs the injections here. He came out of orthopaedics and brought that hands-on background with him. Dr. Gopal Grandhige, our board-certified general surgeon, reviews the plans and doesn’t inject.
Before anyone gets a protocol, health and diet get assessed. Sleep gets looked at as a sleep problem first. That means asking about apnea, shift work, alcohol, thyroid and iron before anyone reaches for a vial. American College of Physicians guidance puts cognitive behavioral therapy ahead of medication for chronic insomnia. Neither that guideline nor the American Academy of Sleep Medicine mentions this peptide at all. Nutrition, supplements and peptides then get adjusted in the window where they can do something. We track the bloodwork that matters rather than going on feel.
An in-office consultation with Dr. Grandhige carries a fee and works as a full clinical assessment. That fee applies toward any procedure or product at the practice. If you’d rather start smaller, Hanna offers a complimentary virtual evaluation to talk through goals and sketch a plan before you come in.
The molecule is interesting and the marketing is ahead of it.
Fifty years after discovery, there’s still no identified gene, no precursor protein and no specific receptor for it. The animal data are real. The human data are old and small. They came from a route nobody sells, and the labs that didn’t discover the molecule couldn’t reproduce them. DSIP and sleep research may eventually produce something worth prescribing. It hasn’t yet, and we’re not going to pretend otherwise while a patient is paying attention.
What we can say is that the boring version works. Protect your sleep, fix what’s breaking it, and let the peptides that have earned their place fine-tune the rest.
No. DSIP isn't approved by the FDA for insomnia or any other condition. On July 24, 2026, an FDA advisory committee voted against adding it to the list of substances pharmacies can legally compound. It was the only rejection among seven peptides reviewed that week. Advisory votes aren't binding, but nothing about that outcome moved it closer to legal access.
It shows a split. Studies from the group that discovered the peptide reported shorter sleep onset and better sleep efficiency, while independent double-blind trials found weak or no differences. The strongest independent trial ran in 16 chronic insomniacs in 1992. It found a shorter sleep latency and no change in subjective sleep quality. Its authors concluded short-term treatment isn't likely to be of major therapeutic benefit.
No. Every controlled human sleep study used intravenous dosing in a laboratory setting. FDA's 2026 review found no data at all for the subcutaneous route. That's the form sold online and discussed in peptide circles.
Not really. Melatonin is a hormone that signals your body clock and acts at known melatonin receptors. DSIP has no identified receptor after nearly fifty years of study. Its effects on sleep in animals appear to run partly through enkephalin release rather than a direct sleep circuit.
Because the scientists involved disagreed publicly about why the work stalled, and because the positive human results were never independently reproduced at scale. One side argued the peptide simply didn't perform. The other argued funding dried up before it got a fair test. Both positions are still findable in the literature.
Nobody can answer that at a regulatory standard. Short-term studies in small groups reported reasonable tolerability. But there are no repeat-dose toxicity studies, no reproductive studies, and no long-term safety data for repeated injection. FDA also flagged the potential for immune reactions from peptide aggregates and impurities in material that hasn't been fully characterized.
No. There's no legal compounding pathway for it, and Formation works only with human-grade compounds from licensed pharmacies. If sleep is what brought you in, we'd rather screen for what's actually breaking it and build a plan around the things with evidence behind them.
The next step after losing 100 pounds.
After significant weight loss, the skin doesn’t always shrink back to match the body’s new shape. And no amount of exercise can remove that excess skin.
In this surgery, Dr. Gopal performs a 360° circumferential body lift to remove excess skin and reshape the patient’s waistline, abdomen, and lower back.
The approach involves lifting the skin on the back and pulling it downward on the front to create a smoother, flatter contour while positioning the incision low enough to be concealed by underwear.
This patient lost over 100 pounds. During surgery, Dr. Gopal explains how approximately 3 pounds of skin were removed from the back, with another 5 pounds planned for removal from the front.
It’s not just about removing skin. It’s about reshaping the body after a significant weight-loss journey.
📍 Dr. Gopal Grandhige | Formation, South Tampa
Interested in body contouring after major weight loss? Schedule a consultation to explore your options.
#BodyLift #CircumferentialBodyLift #ExcessSkinRemoval #WeightLoss #BodyContouring
There’s lean. Then there’s sculpted.
High-definition liposuction goes beyond traditional fat removal. It’s about strategically sculpting around the underlying muscles to create more visible definition in the chest, abdomen, and waist.
For this patient, the goal was a leaner, more defined, athletic appearance without an exaggerated look.
Dr. Gopal Grandhige specializes in male HD liposuction, customizing each procedure to the patient’s anatomy, muscle structure, and desired level of definition.
The result? A more sculpted physique that complements his natural build.
Interested in HD liposuction? Schedule a consultation with Dr. Gopal at Formation Tampa. Link in bio.
Actual patient photos. Individual results vary.
#HDLiposuction #MaleLiposuction #HighDefinitionLiposuction #BodySculpting #Tampa
“That responsibility means everything to me.”
When a patient chooses a plastic surgeon, they’re placing an extraordinary amount of trust in someone else’s hands.
And that responsibility goes far beyond what happens in the operating room.
For Dr. Gopal, it means taking the time to understand each patient’s goals, carefully planning their procedure, making thoughtful decisions throughout surgery, and being there for them during recovery.
Every detail matters because there’s a real person behind every procedure, with hopes, concerns, and expectations.
And that person deserves to feel cared for every step of the way.
#Tampa #CosmeticSurgery #PatientCare #bodycountouring #hdliposuction
Every body needs a different plan.
An HD liposuction consultation with Dr. Gopal is much more than discussing which areas to treat.
He takes the time to evaluate each patient’s anatomy, explain what he’s seeing, and walk through exactly how he would approach the procedure.
Where should fat be removed? Where should it be preserved? How can the waist be sculpted while maintaining natural curves? And when might additional skin tightening be needed?
These are just some of the decisions Dr. Gopal walks patients through, explaining not only what he recommends, but why.
This Reel is a small glimpse into a consultation that typically involves a much more detailed conversation, with time for patients to ask questions and understand their options.
📍 Formation | South Tampa
Considering high-definition liposuction? Schedule a consultation with Dr. Gopal to discuss your goals and explore what’s possible.
#HDLipo #HighDefinitionLiposuction #BodyContouring #Tampa
There’s lean. Then there’s sculpted.
For some men, even years of consistent training and cutting cycles don’t produce the abdominal definition they’re working toward.
Here’s what one patient shared in his Google review of Formation:
⭐️⭐️⭐️⭐️⭐️
“Waited a few months to write this because I wanted to make sure the results held up.
The HD technique did what years of cutting cycles couldn’t. Abs actually show now, even relaxed, even in bad lighting. If you’ve chased a six pack for years you know what that means. Recovery was more involved than I expected and the bruising was wild for a bit. But the result looks like me, just leaner and more defined. Doesn’t look surgical, which was my biggest fear going in. Would recommend, but only if you’re already putting in the work.”
Dr. Gopal Grandhige specializes in male high-definition liposuction, an advanced body-contouring technique that goes beyond traditional fat removal.
By strategically removing fat around the underlying muscles, HD liposuction can enhance natural muscle definition and create a leaner, more sculpted, athletic appearance.
The goal isn’t to create artificial abs. It’s to reveal and enhance the muscle contours already there, with the level of definition customized to each patient’s anatomy and goals.
📍 Formation, South Tampa
Interested in male HD liposuction? Schedule a consultation with Dr. Gopal to explore your options.
Google patient review.
#HDLiposuction #MaleLiposuction #BodyContouring #Tampa
Crunches can only do so much.
You can spend hours strengthening your abdominal muscles, but that doesn’t guarantee visible definition.
A layer of fat sits between the muscles and the skin, and crunches can’t specifically target that fat.
For many people, exercise and reducing overall body fat can help reveal their abs. But even people who are already lean and fit can have stubborn fat that hides their natural muscle definition.
That’s where high-definition liposuction may help.
Dr. Gopal uses HD lipo to selectively remove fat around the natural contours of the abdominal muscles, helping reveal the definition that’s already there.
📍 Formation | South Tampa
Interested in HD lipo? Schedule a consultation to learn more.
#HDLipo #HighDefinitionLiposuction #AbdominalSculpting #BodyContouring
Which one had surgery 1 or 2? 👀
High-definition liposuction goes beyond traditional fat removal. Instead of simply reducing fat evenly, the surgeon strategically removes fat around the underlying muscles to make their natural contours more visible.
But here’s what makes it interesting: HD lipo doesn’t create the same six-pack on everyone. Each person’s anatomy, muscle development, and desired level of definition influence the final result.
Now take another look at these two patients.
Which one do you think had HD liposuction, 1 or 2?
Drop your guess below, then check the pinned comment for the answer!
#HDLiposuction #MaleLiposuction #BodyContouring #Tampa
There’s a story behind every decision.
Cosmetic surgery is a personal decision. Yet people who choose it often find themselves having to explain or defend that choice to others.
Some want to restore changes after pregnancy or weight loss. Others have worked hard to get in shape but still have areas they’d like to improve. And some simply want to feel more comfortable with their appearance.
The reasons are different for everyone. And they don’t have to make sense to anyone else.
At Formation, Dr. Gopal believes the decision to pursue cosmetic surgery should be guided by a patient’s personal goals, realistic expectations, and what’s medically appropriate for them.
Because ultimately, the person making that decision is the one who will live with it.
#Tampa #CosmeticSurgery #BodyContouring #Liposuction
Our first four-legged patient. 🐾
Dr. Gopal takes his liposuction and body contouring very seriously.
Even when his patients have four legs.
From loose skin and neck liposuction to a jawline that deserves its own before-and-after reveal, this might be his most dramatic transformation yet.
And yes, he even got the patient’s permission to share the results. 😂
A little Halloween fun from Dr. Gopal and his two very patient pups! 🎃🐶
No dogs underwent surgery. Just two willing participants and one very committed surgeon.
#SurgeonLife #tampa #necklipo
What weight loss can’t fix.
After losing over 100 pounds, this patient had achieved significant weight loss, but was left with excess skin around his abdomen and back that weight loss alone couldn’t address.
During an 8-hour surgery, Dr. Gopal performed a circumferential body lift, a procedure that removes excess skin around the entire midsection to improve body contour.
In this video, Dr. Gopal walks through the procedure, explaining how he removed approximately 3 pounds of skin from the back and estimated another 4–5 pounds would be removed from the abdomen.
He’s also using a small amount of fat collected during the procedure to add volume to the upper chest, improving its contour without performing a separate chest lift.
For patients who have experienced major weight loss, body contouring can help address the excess skin that remains after the weight is gone.
Considering surgery after weight loss? Schedule a consultation with Dr. Gopal at Formation in Tampa to explore your options.
Actual patient footage. Individual results vary.
#BodyContouring #BodyLift #ExcessSkinRemoval
References:
Graf, M. V., & Kastin, A. J. (1984). Delta-sleep-inducing peptide (DSIP): A review. Neuroscience and Biobehavioral Reviews, 8(1), 83–93. https://pubmed.ncbi.nlm.nih.gov/6145137/
Graf, M. V., & Kastin, A. J. (1986). Delta-sleep-inducing peptide (DSIP): An update. Peptides, 7(6), 1165–1187. https://pubmed.ncbi.nlm.nih.gov/3550726/
Schneider-Helmert, D. (1984). DSIP in insomnia. European Neurology, 23(5), 358–363. https://doi.org/10.1159/000115714
Tukhovskaya, E. A., Ismailova, A. M., Shaykhutdinova, E. R., Slashcheva, G. A., Prudchenko, I. A., Mikhaleva, I. I., Khokhlova, O. N., Murashev, A. N., & Ivanov, V. T. (2021). Delta sleep-inducing peptide recovers motor function in SD rats after focal stroke. Molecules, 26(17), Article 5173. https://pmc.ncbi.nlm.nih.gov/articles/PMC8434407/
Tukhovskaya, E. A., Shaykhutdinova, E. R., Ismailova, A. M., Slashcheva, G. A., Prudchenko, I. A., Mikhaleva, I. I., Khokhlova, O. N., Murashev, A. N., & Ivanov, V. T. (2021). DSIP-like KND peptide reduces brain infarction in C57Bl/6 and reduces myocardial infarction in SD rats when administered during reperfusion. Biomedicines, 9(4), Article 407. https://pubmed.ncbi.nlm.nih.gov/33918965/
Peptides optimize the effort you are putting in. Get a FREE 15-minute Virtual Protocol Review + our Regenerative Treatment Newsletter.
We’ll show you exactly how we evaluate candidacy — plus, we cover the cost of your baseline labs with all in-person consults ($100).
